CADL
Candel Therapeutics, Inc.
+0.35 (+3.18%)11.37USD282K成交股數870M市值–本益比(近四季)4438.9股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 19.8M | 9.8M | 11.0M | 8.5M | 7.0M | 4.0M | 5.4M | 5.0M | 4.1M | 7.3M | 5.8M | 5.9M |
| 銷售管理費用 | 6.9M | 6.4M | 4.7M | 4.7M | 4.2M | 4.1M | 3.3M | 3.6M | 3.8M | 3.1M | 3.0M | 3.6M |
| 營業利益 | −26.7M+139% | −16.3M+100% | −15.8M+80% | −13.2M+54% | −11.2M+41% | −8.1M-21% | −8.8M-1% | −8.6M-11% | −7.9M | −10.3M | −8.9M | −9.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −38.9M+711% | −8.9M-220% | −29.5M+177% | −11.3M-49% | −4.8M-42% | 7.4M-167% | −10.6M+26% | −22.2M+131% | −8.2M | −11.1M | −8.4M | −9.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.52+478% | -0.14-208% | -0.55+67% | -0.21-72% | -0.09-68% | 0.13-133% | -0.33+14% | -0.74+124% | -0.28 | -0.39 | -0.29 | -0.33 |
| 稀釋股數 | 74.1M | 62.4M | 53.0M | 54.9M | 51.5M | 54.8M | 32.0M | 29.9M | 29.2M | 28.9M | 28.9M | 28.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 202M | 195M | 120M | 87.0M | 101M | 92.2M | 16.6M | 21.5M | 25.7M | 35.4M | 43.0M | 51.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 208M | 202M | 125M | 93.6M | 106M | 95.9M | 21.5M | 26.5M | 31.2M | 41.2M | 50.1M | 58.7M |
| 有息負債 | – | – | – | – | – | – | 4.2M | 6.7M | 9.2M | 11.6M | 14.3M | 16.7M |
| 總負債 | 82.0M | 63.9M | 73.3M | 13.5M | 15.8M | 21.2M | 36.8M | 36.5M | 25.2M | 28.5M | 27.0M | 27.9M |
| 股東權益 | 126M | 138M | 51.9M | 80.1M | 90.2M | 74.7M | −15.3M | −10.0M | 6.0M | 12.7M | 23.0M | 30.8M |
| 負債比 | 39.4% | 31.6% | 58.5% | 14.4% | 14.9% | 22.1% | 170.9% | 137.7% | 80.8% | 69.1% | 54.0% | 47.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | 12.3M | 14.7M | 16.5M | 23.8M | 28.6M | 35.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −18.0M+109% | – | – | – | −8.6M | – | – | −8.4M | – | – | – |
| 資本支出 | – | 675K | – | – | – | 3K | – | – | 7K | – | – | – |
| 自由現金流 | – | −18.7M+117% | – | – | – | −8.6M | – | – | −8.4M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | 200K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −38.2M | –% | -0.72 | −38.9M |
| FY2024 | – | – | −55.2M | –% | -1.74 | −27.0M |
| FY2023 | – | – | −37.9M | –% | -1.31 | −34.7M |
| FY2022 | 125K | 0.0% | −18.8M | -15,035.2% | -0.65 | −32.7M |
| FY2021 | 125K | 0.0% | −36.1M | -28,899.2% | -1.91 | −24.1M |
| FY2020 | 125K | – | −17.7M | -14,144.0% | -1.52 | −10.5M |